AstraZeneca said the U.S. Food and Drug Administration approved Datroway, a treatment for metastatic breast cancer developed in combination with Daiichi Sankyo.

DATROWAY® (datopotamab deruxtecan-dlnk) has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone receptor (HR)-positive, HER2-negative (IHC 0, IHC 1+ or ...

DATROWAY Approved in the U.S. for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer ...

Arkansas’ own statistics show much work to be done. Per a 2023 press release from the Arkansas Department of Health, nearly ...

Cancer incidence continues to rise for many common cancers—especially for women. The incidence rate for women younger than 50 ...

Several major drugmakers have restricted commercially insured patients from their patient assistance programs, leaving ...

Adjuvant ado-trastuzumab emtansine significantly prolonged survival compared with trastuzumab for certain women with ...

Let's talk about something that's tough but important: how to be there for your wife during breast cancer treatment. W ...

Oxford University researchers have unveiled a new blood test, powered by machine learning, that shows promise in detecting ...

"During Joe Rogan’s podcast on Jan. 9, Mel Gibson promoted drugs that are not scientifically proven cancer treatments," the ...

Dr. Liz O'Riordan wants people to know that there is no "magic fix" and no special diet that will cure cancer, despite many of the online claims out there.

They say cancer is the result of pent-up anger and resentment. Apparently, years of holding on to these emotions make your ...